BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 29512078)

  • 1. Unbiased Lipidomics and Metabolomics of Human Brain Samples.
    Astarita G; Stocchero M; Paglia G
    Methods Mol Biol; 2018; 1750():255-269. PubMed ID: 29512078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Throughput Lipidomic and Metabolomic Profiling for Brain Tissue and Biofluid Samples in Neurodegenerative Disorders.
    Thompson BM; Astarita G
    Methods Mol Biol; 2024; 2785():221-260. PubMed ID: 38427197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics and lipidomics using traveling-wave ion mobility mass spectrometry.
    Paglia G; Astarita G
    Nat Protoc; 2017 Apr; 12(4):797-813. PubMed ID: 28301461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometry: from proteomics to metabolomics and lipidomics.
    Griffiths WJ; Wang Y
    Chem Soc Rev; 2009 Jul; 38(7):1882-96. PubMed ID: 19551169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipidomics in the study of lipid metabolism: Current perspectives in the omic sciences.
    Rolim AE; Henrique-Araújo R; Ferraz EG; de Araújo Alves Dultra FK; Fernandez LG
    Gene; 2015 Jan; 554(2):131-9. PubMed ID: 25445283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing the lipidomics workflow for clinical studies--practical considerations.
    Hyötyläinen T; Orešič M
    Anal Bioanal Chem; 2015 Jul; 407(17):4973-93. PubMed ID: 25855150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Cerebrospinal Fluid Sample Preparation and Annotation for Integrated Lipidomics and Metabolomics Profiling Studies.
    Hooshmand K; Xu J; Simonsen AH; Wretlind A; de Zawadzki A; Sulek K; Hasselbalch SG; Legido-Quigley C
    Mol Neurobiol; 2024 Apr; 61(4):2021-2032. PubMed ID: 37843799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of mass spectrometry-based targeted and non-targeted lipidomics.
    Lee HC; Yokomizo T
    Biochem Biophys Res Commun; 2018 Oct; 504(3):576-581. PubMed ID: 29534960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass Spectrometry-Based Untargeted Metabolomics and Lipidomics Platforms to Analyze Cell Culture Extracts.
    Iturrospe E; da Silva KM; van de Lavoir M; Robeyns R; Cuykx M; Vanhaecke T; van Nuijs ALN; Covaci A
    Methods Mol Biol; 2023; 2571():189-206. PubMed ID: 36152163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances of chromatography and mass spectrometry in lipidomics.
    Li M; Zhou Z; Nie H; Bai Y; Liu H
    Anal Bioanal Chem; 2011 Jan; 399(1):243-9. PubMed ID: 21052649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current state-of-the-art of separation methods used in LC-MS based metabolomics and lipidomics.
    Harrieder EM; Kretschmer F; Böcker S; Witting M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jan; 1188():123069. PubMed ID: 34879285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancing the large-scale CCS database for metabolomics and lipidomics at the machine-learning era.
    Zhou Z; Tu J; Zhu ZJ
    Curr Opin Chem Biol; 2018 Feb; 42():34-41. PubMed ID: 29136580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extraction of Plant Lipids for LC-MS-Based Untargeted Plant Lipidomics.
    Rupasinghe TWT; Roessner U
    Methods Mol Biol; 2018; 1778():125-135. PubMed ID: 29761435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ion mobility mass spectrometry in the omics era: Challenges and opportunities for metabolomics and lipidomics.
    Paglia G; Smith AJ; Astarita G
    Mass Spectrom Rev; 2022 Sep; 41(5):722-765. PubMed ID: 33522625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the application range and selectivity of a differential mobility spectrometry-mass spectrometry platform for metabolomics.
    Wernisch S; Afshinnia F; Rajendiran T; Pennathur S
    Anal Bioanal Chem; 2018 May; 410(12):2865-2877. PubMed ID: 29532192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unbiased Metabolomic Investigation of Alzheimer's Disease Brain Points to Dysregulation of Mitochondrial Aspartate Metabolism.
    Paglia G; Stocchero M; Cacciatore S; Lai S; Angel P; Alam MT; Keller M; Ralser M; Astarita G
    J Proteome Res; 2016 Feb; 15(2):608-18. PubMed ID: 26717242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometric based approaches in urine metabolomics and biomarker discovery.
    Khamis MM; Adamko DJ; El-Aneed A
    Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Merging metabolomics and lipidomics into one analytical run.
    Schwaiger M; Schoeny H; El Abiead Y; Hermann G; Rampler E; Koellensperger G
    Analyst; 2018 Dec; 144(1):220-229. PubMed ID: 30411762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomic and lipidomic assessment of the metabolic syndrome in Dutch middle-aged individuals reveals novel biological signatures separating health and disease.
    Surowiec I; Noordam R; Bennett K; Beekman M; Slagboom PE; Lundstedt T; van Heemst D
    Metabolomics; 2019 Feb; 15(2):23. PubMed ID: 30830468
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.